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This article 
ABSTRACT 
describes a microparticle enhanced nephelometric 
immunoassay (Ne AeliaR) applied to the quantification of the thymic 
peptide hormone &pulin. NepheliaR uses antibody recognition by the anti- 
thmulin antiserum in a comuetitive reaction between free thmulin and 
th$nulin bound to the microsiheres. The binding between microsphere and 
thymulin is achieved with the aid of a protein carrier. The sensitivity of the 
competitive reaction varied with the protein carrier and the antiserum 
sample. The most efficient reaction was obtained with the thymulin- 
metallothionein-microsphere conjugates; as little as 5 g/ml of thymulin 
synthetic thymulin was totally recovered. Measurement of thymulin in serum 
or ultra-filtrate samples demonstrated the presence of interference from 
molecules in the serum. NepheliaR led to the same conclusions as those 
reported with other methods and performs as well, and is more simple to 
use than radio- or enzymo-immunoassays for thymulin measurement. 
(KEY WORDS : nephelometry; micro article immunoassay; NepheliaR; 
synthetic t h y m h ,  polyclonal antibodies? 
could be detected. In adult human serum, or in its up tra-filtrate, spiked 
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INTRODUCTION 
Thymulin, discovered by Bacch et al. (l), and formerly called “serum 
thymic factor”, is a thymic hormone involved in several aspects of extra- and 
intra-thymic T cell differentiation (2). Thymulin is a nonapeptide (Glp-Ala- 
Lys-Ser-Glu-Gly-Gly-Ser-AsnOH) (3). The synthetic hormone has been 
shown to be biologically active (3) and demonstrates the same 
physicochemical characteristics as the natural hormone (4). Teams using 
immunochemical assays perfected for synthetic thymulin have reported 
interference from molecules in the serum (5-8). It is not possible to perform 
direct specific quantification of natural thymulin in serum samples; 
extraction of serum is still necessary to eliminate interfering biological 
molecules (8,9). In the absence of a direct biochemical assay, the 
determination of thym& can st i l l  be done using a biological assay 
developed by Dardenne and Bach (10). Extensive use of the biological test 
is limited by the fact that it is only a semi-quantitative assay. Moreover other 
thymic hormones, such as thymopoietin (11) and thymosin d l  (12), as well as 
an allogeneic factor from activated T cells (13,14), also show activity in the 
biological assay. The determination of thpulin levels in biological fluids is 
critical for the study of immune disorders. Thus a specific method for direct 
measurement of thymulin is needed. 
We used a new microparticle enhanced nephelometric immunoassay, 
NepheliaR, which is simple, rapid and very sensitive, for thymulin 
measurement. NepheliaR has very recently been successfully applied to 
serum and milk proteins (15-17) and is marketed by Diagnostics Pasteur 
(Marnes-la-Coquette, France). The synthesis of a stable microparticle 
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reagent on which polypeptides can be covalently coupled by simple 
incubation has been developed (18). The binding of several antigen 
molecules to one microsphere makes it possible to assay haptens such as 
thpulin. Immunonephelometry measures the light scattered by the 
turbidity of antigen-antibody complexes formed through the antigen- 
antibody reaction. The increased size of the antigen, due to its binding to 
the microsphere, and formation of an enlarged antigen-antibody complex, 
provides for earlier detection of the reaction by the nephelometer, giving 
improved accuracy to this method. We describe the application of 
NepheliaR to thymulin measurement in a competitive reaction between free 
thymulin and the microsphere-bound peptide, for binding to polyclonal 
antibodies. 
MATERIALS AND lMETHODS 
Reasents 
Synthetic thymulin (S8256), chicken ovalbumin (A5503), polyaspartic 
acid ( P U )  (P5387), and metallothionein (MT) (M7641) were obtained 
from Sigma (St Louis, MO). N-(3 dimethylaminopropy1)-N ethyl- 
carbodiimide hydrochloride, acrolein (800178), methacrylic acid (800578), 
hydroxyethylmethacrylate (800588) were provided by Merck (Darmstadt, 
F.R.G.). N,N'-methylene bisacrylamide was obtained from Eastman Kodak 
Company (Kingsport, Tennessee). Bovine serum albumin (BSA) was from 
IBF (Villeneuve la Garenne, France). All other chemical reagents were of 
analytical reagent grade. Freund's complete or incomplete adjuvant was 
from Behring Institut (Marburg, F.R.G.). Polystyrene micro-cuvettes were 
from Ratiolab (Buchschlag, F.R.G.). 
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Anti Thymulin Antiserum 
Syathetic thymulin was covalently bound to chicken ovalbumin 
carrier (1/4, w/w) in the presence of 4 mM glutaraldehyde (19). The 
mixture was stirred for 3 hours at room temperature. The reaction was 
stopped using 15.8 mM sodium bisulfite and the conjugate dialyzed against 
0.1 M phosphate buffer, pH 7.4, containing 0.15 M NaC1. Eight six-week-old 
"Roux de Bourgogne" rabbits were immunized according to a protocol 
previously described by Monier et al. (20) and already used by our team 
(21). For each shot, immunogen containing 0.5 mg thymulin was injected. 
Rabbits received mdtiple subcutaneous injections with ovalbumin-thym& 
conjugate in the presence of Freund's complete adjuvant (1/2, v/v). Four 
months later, the rabbits were boosted with immunogen and incomplete 
Freund's adjuvant (1/2, v/v). The booster dose was then again administered 
after 10 weeks, and yet again 4 months later. 
Synthesis of the Microuarticle Reagent 
The microparticle manufacturing process is covered by a patent (18). 
Microspheres employed here were obtained by irradiation, under a cobalt 
60 source (ORIS, Nucleart, CENG, France) (23 Krad/cm2/h for 3 hours), 
of a mixture containing 5 % (v/v) total monomers (of the 5 % : 49.7 % (v/v) 
hydroxyethylmethacrylate, 47 % (v/v) acrolein, 2 % (v/v) methacrylic acid 
and 1.3 % (w/v) Ny"-methylene-bis-amylamide) in a 0.6 g/1 sodium 
dodecyl sulfate solution. Microspheres thus obtained had an average 
diameter of 105 nm (measured by transmission electron microscopy). 
Microspheres were hydrophilic, stable in suspension and reactive, which 
allowed covalent coupling with the protein. Microspheres were stored at 
+4"C in a reducing medium (hydroquinone). 
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Preparation of the Protein-Microsuhere ConjuPateg 
Three proteins were used : bovine serum albumin (BSA), 
polyaspartic acid (PAA) and metallothionein (MT). Coupling medium was 
0.3 M NaCl, 0.1 M borate buffer, pH 8.2 for BSA, and 0.15 M NaCl, 0.01 M 
phosphate buffer, pH 7.2 for the other two carriers. Coupling was carried 
out by an overnight incubation (at +4"C) of the protein with 10 mg/ml 
microspheres previously dialyzed in the coupling medium. Microsphere 
aldehyde groups which had not reacted were blocked with 0.12 M 2- 
aminoethanol, prepared in coupling medium buffered with acetic acid at pH 
8, for 1 hour at room temperature. Microspheres grafted with PAA were 
saturated with final 0.036 M glycin instead of 2-aminoethanol. Imine bonds 
between microsphere and PAA were reduced with sodium borohydride 
(BH4Na) (5 mg for 10 mg microspheres) at pH 8-9 during 2 hours stirring. 
The pH was then adjusted to 6 with 1 M acetic acid. After coupling, excess 
BSA or PAA was eliminated by ultracentrifugation on a 200-800 g/1 
discontinuous sucrose gradient then dialyzed in coupling medium, while 
MT, whose molecular weight is 6 400 Dy was simply dialyzed. 10 mg of 105 
nm diameter microspheres were coupled with either 2 x BSA moles, 5 x 
10-7 PAA moles or 2 x 10-8 MT moles. 
Couplin? of Thpul in  to the Protein-Microsphere Conjucrates 
Carboxylic groups of the bound protein were activated in 0.14 M 
NaCl, pH 6.5, by N-(3 dimethylaminopropy1)-N ethyl-carbodiimide 
hydrochloride (22), 5 mg per 10 mg of protein-microspheres. Thymulin was 
then added, and the whole preparation incubated for 4 hours at room 
temperature. 4 M urea (250~1/10 mg microspheres) was added to block the 
remaining activated groups of the proteins. Thymulin-protein microspheres 
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thus prepared were stored at +4"C in 0.15 M NaCl, 0.01 M phosphate 
buffer, pH 7.2 after dialysis to eliminate excess urea and uncoupled 
thymulin. 10 mg of BSA-microspheres, PAA-microspheres and MT- 
microspheres were coupled with and thymulin moles 
respectively. 
Assav Buffers 
The assay used 0.05 M sodium phosphate buffer, pH 7.2, containhg 
0.33 M NaC1,2g/l Triton XlOO and 2 g/l NaN3 Development of the assay 
medium was carried out by choosing buffer components accordhg to the 
results of the agglutination reaction. In some experiments, the assay was 
performed with the addition of zinc salt. In this case the non sequestrating 
assay buffer was 0.01 M HEPES, pH 7.5, containing 0.2 M NaCl, 2 g/1 
Triton X100,2 g/1 NaN3 and the additives chosen for phosphate buffer. 
Assav Procedure 
AU reagents were prepared in the assay buffer. AU reactions were 
performed at room temperature and the result was measured using a 
Behring nephelometer (Behring Institut, Marburg, F.R.G.). The 
nephelometric reference signal was given by the agglutination of thymulin- 
protein microspheres with anti-thymulin antibodies. The reaction was 
performed in a total volume of 300y.1; antiserum (150yl) was prepared in a 
serial dilution in each cuvette then 150 1 of the thymulin-protein 
microspheres were added. The agglutination curve was drawn and used to 
choose eflïcient concentrations of thymulin-protein microspheres and 
dilution of antiserum. For the competitive reaction, synthetic thymub (150 
p) was first added in a serial dilution, antiserum (75yl) was then added. Both 
P 
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were incubated together for 30 min before thymulin-protein microspheres 
(75pl) were added. For the assay of biological samples, 150yl of the sample 
diluted in 0.14 M NaCl, pH 6.5, or 150~1 of only 0.14 M NaCl, pH 6.5 for the 
reference signal, were first added, antiserum and the thymulin-protein 
microspheres were then added as described above but diluted in a 2 times 
concentrated assay buffer. The results are shown as intensity of scattered 
light, i.e. voltage recorded by the nephelometer, in relation to thymulin 
concentration. Agglutination percentage compared with the nephelometric 
reference signal can thereby be calculated. 
Serum Samdes 
Serum samples were obtained from 50 children and 92 adult donors. 
f i e  serum was ultra-filtered by centrifugation, at room temperature, using 
ready for use Centrisart-I tubes (Sartorius, Göttingen, F.R.G.) containing a 
filtration membrane with a cut-off at the molecular weight of 20 O00 D. A 
preliminary verification showed that thymulin-protein microspheres were 
stable at usual working dilutions in human serum and ultra-filtrate samples. 
For recovery studies, synthetic thymulin was added to a pool of sera 
from 15 adult donors, supposedly without native thym% and recovery 
measured in the 1/300 serum and 1/4 ultra-filtrate. At the same time, a 
standard curve was established in each of the two biological media (1/300 
serum and 1/4 ultra-filtrate) and was directly used to express thymulin 
concentration results. 
Precision of the recovery was assessed by measuring 3 concentrations 
of thymulin in 1/4 ultra-filtrate 20 times with the same standard curve on 
the same day (within-run precision), and over 9 days by 5 assays repeated on 
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days 1, 2, 5, 7, and 9 with a new standard curve each day (between-run 
precision). 
RESULTS 
Antisera 
Normal rabbit serum obtained before immunization showed no 
agglutination with any of the three thymulin-protein microspheres. No 
agglutinating anti-thpulin antibodies were obtained after the first injection, 
and after the first booster injection, antibodies were produced after two 
weeks. Three different antiserum samples, taken from the same rabbit, were 
used for all the reactions presented here. They were A antiserum (32 days 
after the first booster injection), B antiserum (42 days after the first booster 
injection), C antiserum (12 days after the second booster injection). 
Muence of the Reaction Medium on Agglutination 
Compared to the complete buffer tested (0.05 M sodium phosphate, 
pH 7.2, containing 0.33 M NaCl, 30 g/l PEG 6000, 1.50 mlM EDTA, 2 g/l 
Triton Xl00 and 2 g/1 N a 3 ) ,  EDTA-free buffer did not modify the 
agglutination intensity (Fig. l), which is understandable because phosphate 
buffer is also a chelating medium for divalent ions. It is essentially the PEG 
which was responsible for the amplification of the agglutination reaction. 
The pH sensitivity of the agglutination reaction was assessed under the same 
working conditions as in Fig. 1. The agglutination reaction was performed in 
the complete phosphate buffer at pH 7.5 and 8.0 in comparison with pH 7.2 
initially chosen. M ; o r i "  agglutination was obtained at 1/96 antiserum for 
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HGURE 1. utination of 0.2 m g / d  th ulin-MT-microspheres by B 
antiserum in 8 erent buffers : complete b 2 er (0.05 M sodium phosphate, 
pH 7.2, containing 0.33 M NaCl, 30 g/1 PEG 6000, 1.50 mM EDTA, 2 g/1 
Triton XlOO and 2 g/l NaN ) ( o  complete buffer without EDTA ( + ), 
and complete buffer without%EG ?* ), t = 120 11111. 
all pH values. The signals were 6.92, 6.08 and 2.40 volts for pH 7.2,7.5 and 
8.0 respectively. Results therefore differed little at pH 7.5 but were much 
lower at pH 8.0. 
To study a medium allowing the addition of zinc, complete HEPES 
buffer was used, with EDTA, or without EDTA with added zinc chloride 
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Inverse of antiserum dilution Inverse of antiserum dilution 
the C antiserum in 0.01 M HEPES, 
ZEG 6000,2 g/1 Triton XlOO and 2 
3DTA ( * ) or with 0.56m zinc 
ymulin-PAA-microspheres and (b): 
(ZnCl2) resulting in a zinc concentration of 0.56pM. The agglutination of 
the thymulin-PAA-microspheres (Fig. 2-a) was weak but most intense in the 
presence of EDTA. This difference increased when thymulin-MT- 
microspheres were used (Fig. 2-b). MT was therefore the protein carrier 
with the most sensitive agglutination reaction to the presence of zinc or 
EDTA in the medium. 
All these results showed the sensitivity of the agglutination reaction 
to changes in the reaction medium. 0.05 M sodium phosphate, pH 7.2, 
containing 0.33 M NaCl, 30 g/l PEG 6000, 1.50 mM EDTA, 2 g/1 Triton 
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TABLE 1 
Competitive reaction of synthetic thymulin and the 3 kinds of 
thymulin-protein-microspheres with the A antiserum, in complete 
phosphate buffer. 
A 
Antis- 
Dilution 
Spacer micro- I 1 spheres Assay Concentration of Thymulin (nglml) Time (&) required to give % of agglutination 
of 
90 % 50 % 10 % 
PAA 0.200 El$!z 1/100 u200 1/75 105 0.214 21.63 80.98 100 0.354 8.78 39.13 60 0.078 1.11 15.18 
XlOO and 2 g/1 NaN3, called complete buffer, gave the best results and was 
consequently chosen for further tests. 
Optimisation of Workinp Conditions : Choice of Protein Carrier and 
Antiserum Batch for the Competitive Reaction 
Assessment of the optimal assay time, the optimal concentration of 
the three kinds of thymulin-protein microspheres and the optimal dilution of 
the A antiserum for the competitive reaction led to the use of different 
conditions in each case to obtain the lowest concentration of competing 
thymulin required to give a significant signal reduction (Table 1). 
Agglutination was entirely specific since synthetic thymulin was able to 
totally inhibit the reaction. The most sensitive reaction was obtained with 
the thymulin-MT-microspheres, whereas the least sensitive reaction was 
obtained with the thymulin-BSA-microspheres. Fig. 3 shows the competitive 
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HGURE 3. Competitive reaction of synthetic thpulin and 0.033 mg/ml 
thym&-MT-microspheres with 1/400 C antiserum, in complete phosphate 
bufEer, t = 180 mn (standard curve). Error bars for triplicate measurements 
are presented. 
reaction between thpulin-MT-microspheres and synthetic thymulin, with 
the C antiserum. A thymulin concentration of 226 p g / d  inhibited 50 % of 
the reference agglutination reaction and was a lower concentration than that 
required for the same inhibition percentage with the A antiserum (shown in 
Table 1). Detection was consequently better when using the C antiserum. 
c 
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These results were used to construct the standard curve. Reference 
agglutination was decreased by 10 % with 9.7 pg/ml thym& and the 
thymulin concentration of 5 p g / d  led to 93 % of reference sipal. 
Assay in Serum and Ultra-Filtrate Samples 
Comparison between concentration of added and recovered thymulin 
in biological media is given in Fig. 4. The synthetic thymulin was correctly 
recovered between 8 and 1000 pg/ml in 1/4 ultrafiltrate (r=0.9962, mean 
recovery percentage was 100.18 & 14.30), and between 16 and 500 pg/ml in 
1/300 serum (r=0.9983, mean recovery percentage was 102.56 -C 23.16) 
(Fig. 4). 
Within- and between-run CV studied for 3 concentrations of 
synthetic thymulin ranged between 5.5 and 12.5 % (Table 2). Stability of 
thymulin can be shown by the variations between day 1 and day 9 which 
were : from 7.4 to 4.9 pg/ml, from 90.8 to 73.1 pg/ml and from 1061.5 to 
881.2 pg/ml for the 3 concentrations studied. 
Samples of serum and ultra-filtrate were assayed in the competitive 
reaction. The results were expressed in thymulin concentration according to 
the standard curve. The test of serial dilutions by 2 of the serum pool of 15 
adult donors showed that the concentration of thymulin was linear between 
1/80 and 1/2560 (y= 1.3%-44.35; r=0.9906). Mean thymulin concentrations 
measured in 4 serum dilutions showed no difEerence between sera of 7 adult 
donors, supposedly without thymulin, and sera of 14 children, which should 
contain thpulin (Table 3). When taking into account the serum 1/40 
dilution, serum thpulin levels do not dilute in parallel with the standard 
preparation. The test of serial dilutions by 2 of the ultra-filtrate samples 
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FIGURE 4. Synthetic thymulin concentration @g/ml) recovered after 
incorporation into a serum pool from 15 adult donors then addition in the 
NepheliaR assay into 1/300 serum pool or into 1/4 serum o01 ultra-filtrate, 
media (1/300 serum and 1/4 ultra-filtrate). 
according to a standard curve established in each of t 1 e two biological 
showed a thymulin concentration o€ 31 C_ 8 p g / d  in 1/2 ultra-filtrates of 12 
children and 111 2 12 pg/ml in 1/2 ultra-filtrates of 6 adult donors. 
Concentrations in more diluted ultra-filtrates were lower than expected 
(data not shown). Ultra-filtrate samples were assayed at the 1/2 dilution 
because they inhibited the reference agglutination €ar less than the whole 
serum. The division of the ultra-filtrate samples into different thymulin 
concentration groups (Fig. 5 )  showed that thymulin concentration was 
higher in ultra-filtrates of serum from 70 adult donors than in those from 36 
b 
L 
children 
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TABLE 2 
Within- and between- run precisions of NepheliaR for synthetic 
thymulin recovered in 114 ultra-filtrate. SD = standard deviation ; 
CV = coefficient of variation. 
Within - run Between - run 
n=14 
adults 
n Mean(SD),pg/ml CV,% n Mean(SD),pg/ml CV,% 
20 4.2 (0.3) 7.1 5 6.4 (0.8) 12.5 
20 67.0 (3.7) 5.5 5 78.9 (7.1) 8.9 
20 723.8 (48.0) 6.6 5 945.1 (82.6) 8.7 
(126) (106) (27) (12) 
1125 639 111 40 
TABLE 3 
Mean (k SEM) thymulin concentration (pg/ml) measured in 4 
dilutions of serum from adult donors and children according to the 
standard curve. There was no significant difference between the 
groups at any dilution (p>0.05) (statistical analysis was performed 
by Student's t test). 
I serum dilution 
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O/O of ultrafiltrate samples 
0-30 31-60 61-90 91-120121-150 > 150 
Pg/ml 
FIGURE 5. Division into th 
standard curve. 
ulin concentration groups of 1/2 ultra- 
filtrates of sera from 36 chil (r" en and 70 adult donors, according to the 
children. 47 % of adult donors samples showed a thymulin concentration 
between O and 60 pg/ml, while 86 % of children samples showed thymulin 
concentration in this range. No result above 150 p g / d  was found in 
children samples, whereas 18 % of adult donors samples showed a thymulin 
concentration above 150 pg/ml (maximum value was 1 606 pg/ml). 
c 
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In the present report we describe a potentially useful and sensitive 
immunochemical approach to the measurement of thym& by a 
microparticle enhanced nephelometric immunoassay (NepheliaR). The assay 
is a competitive immunological reaction between the synthetic hormone 
bound to the microsphere and free thymulin, using a specific antiserum. 
The coupling of thymulin required the microspheres to be first 
coated with a protein carrier because the hormone is too small a molecule 
to provide, on its own, an adequate covering, which is essential for the 
stability and the immunoreactivity of the microsphere. On the microsphere 
and in the immunogen, thymulin was attached to the protein carriers 
principally through the €-amino group of Lys-3. The chemical amide link, 
created by carbodiimide on the microsphere protein carrier, was therefore 
different from the one created with glutaraldehyde in the immunogen. This 
avoided any immunological cross-reaction with the coupled microspheres 
through linkage, which should lead to a non-thymuljn specific agglutination. 
The antigenicity of thymulin was maintained in both cases of coupling since 
the C-terminal residue was the same for antibody recognition. Indeed, 
studies on structure-activity relationship with varied synthetic analogs have 
shown that neither Glu1 or Ala2 (9) nor the side chain of Lys-3 (23) were 
necessary for antigenicity. On the contrary, with regards to the C-terminal 
residue, all modifications would abrogate antibody recognition (24). 
t 
There are two forms of thymulin, one biolpgically active containing 
zinc, and the other inactive, free of the metal (25). The presence of this 
metal also makes it possible for a new monoclonal antibody-defined epitope 
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to appear (26). We chose a zinc chelating medium to assay the whole 
peptide regardless of the varied conformations due to the binding of zinc on 
thymulin. On the microsphere, the accessibility of thpulin depends on the 
protein carrier. Thymulin-MT-microspheres agglutinated by the best 
antiserum (C) comprised the most sensitive detection of synthetic thymulin : 
5 pg/ml at 93 % reference agglutination. Thus NepheliaR is sufficiently 
sensitive to be used for quantitating the levels of thymm in human serum. 
For the recovery test, synthetic thymulin was largely distributed over 
the concentration range of the standard curve. Synthetic thym& spiked 
into a serum pool of adult donors was almost completely recovered in a 
dilution of serum or ultra-filtrate. The assay of free synthetic thymulin was 
possible in the whole serum or after the ultra-filtration procedure, and we 
tried to apply NepheliaR for the direct measurement of thymulin content in 
serum and ultra-filtrate samples. The high thymulin concentrations 
measured both in children or adult donors serum samples, supposedly with 
and without thpulin respectively, and the higher thymulin concentration 
measured in ultra-filtrates of adult donor sera when compared with ultra- 
filtrates of children sera, were not consistent with what could be expected 
for the natural thymulin alone. Moreover, a comparison of the results 
obtained from the assay of thymulin in serum and ultra-filtrate samples 
showed that values were approximately 200 times higher in serum than in 
ultra-filtered serum, after correcting for dilution. We concluded that there 
are molecules in serum, partly recovered in the ultra-filtrate, that interfere 
with the reaction. 
Molecules in the serum interfering with the biological assay of 
thymulin have been reported by Bach et al. (2) as having high or low 
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molecular weight (between 100 O00 and 300 O00 D and also between 4 O00 
and 20 O00 D); their level seemed not to vary with age or with blood 
thymulin level. A high molecular weight molecule still interfered with the 
biological assay when serum was of low concentration (1/5 OW) (1). 
Interfering molecules in the serum have also been reported by teams who 
used immunochemical assays perfected for synthetic thymulin (5-8). It is not 
possible to perform a specific quantification on biological samples directly. 
Serum extraction is still necessary to eliminate biological molecules which 
interfer, and the low concentration of thymulin in blood requires sample 
concentration before assay (8,9). Attempts to measure natural serum 
hormone with radio-immunoassays have given values, in the pig, of 100-500 
pg/ml(5) or 32 p g / d  (2) or 22 pg/ml(9) and, in the mouse, of 45 p g / d  
(2) or 1.3 pg/ml(9). A level of 44 pg/ml has been measured in children (6) 
and of 1.49 pg/ml in young people (8). Contradictions in these results reflect 
the considerable complexity of assaying natural thymulin. 
NepheliaR led to the same conclusions as those reported with other 
methods already published, and performs as well. NepheliaR, giving rapid 
results after only a single-step reaction using three reagents without a 
washing or separation phase, is more simple to use than radio- or enzymo- 
immunoassays. NepheliaR is therefore useful in further fundamental work to 
better characterize interfering molecules reported in all biological or 
immunochemical assays of thymulin. Such results are required for the 
development of accurate immunochemical assays for natural thymulin. We 
can hope that NepheliaR could then be useful for direct measurement of 
t h ~ u l i n  in biological media. Moreover, in addition to several assays with 
NepheliaR already published (15-17), our work describes the first 
5 40 
. 
GARTNER ET AL. 
application of this method for the measurement of an hapten and points the 
way to a possible application of NepheliaR in this type of assay. 
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